Stimulation: Transcranial Magnetic Stimulation

What It Is

Transcranial magnetic stimulation is a clinic treatment that uses a magnetic field to influence a targeted patch of the brain from outside the skull. A clinician holds an electromagnetic coil against the scalp, usually over the left front of the head, and the machine sends rapid magnetic pulses through it. Each pulse passes painlessly through the skull and, in the cortex just beneath the coil, induces a small electrical current that makes nearby neurons fire. The person sits awake in a chair, with no anesthesia and no sedation, and feels a tapping on the scalp and hears a clicking from the coil. A single standard session runs about twenty to forty minutes, and a course is one session a day, five days a week, for four to six weeks.

TMS is easy to confuse with electroconvulsive therapy, which people often picture when they hear "brain stimulation." Electroconvulsive therapy passes an electric current across the whole brain under general anesthesia to trigger a brief seizure on purpose, and it is a stronger, more sedating treatment used for the most severe depression. TMS does not aim to cause a seizure, needs no anesthesia, and lets the person drive home afterward. It is delivered in a clinic and is not something done at home, and a full course typically costs several thousand dollars, which insurers often cover only after a few medications have been tried.

How It Works

The magnetic pulse itself is the tool. A brief, strong magnetic field passing through the scalp and skull induces a matching electrical current in the cortex underneath, and that current depolarizes neurons, making them fire. A single pulse produces a momentary effect. What makes TMS a treatment is repetition: delivering pulses in a rhythm, session after session, shifts how excitable that patch of cortex stays for a while after the stimulation stops. Delivered at a fast rhythm the treatment tends to raise excitability in the targeted area; delivered slowly it tends to lower it.

What Happens Across a Course of Treatment

1The first session, and finding the dose

The clinician first measures the motor threshold: pulses over the area that controls the hand, turned up until the thumb twitches, which sets the strength for that person. The treatment coil then moves to the left dorsolateral prefrontal cortex, a region on the mood-regulating network. Pulses feel like a firm tapping on the scalp, sometimes with a headache or a twitch of the face or jaw during the train, and there is a loud click, so earplugs are worn.

2The daily course

Sessions run once a day, five days a week, for four to six weeks in the standard protocol. The antidepressant effect builds gradually over these weeks rather than arriving in one session, which is thought to reflect the cumulative, lasting shift in the excitability of the targeted circuit. Intermittent theta-burst stimulation compresses the standard session into about three minutes, and an accelerated protocol delivers many short sessions a day to finish a course in five days.

3After the course, and keeping it

When a course works, the improvement can persist for months. It does not always hold: over the year that follows, some people relapse, and a repeat course or ongoing maintenance sessions are used to keep the gain. TMS treats the episode and can be repeated, rather than resetting the condition once.

The specific rhythm that most of the newer research uses is theta-burst stimulation, short high-frequency bursts of pulses repeated at about five times a second, the brain's own theta rhythm. In healthy volunteers, applying this pattern over the motor cortex changed how excitable the cortex was for up to an hour after a stimulation lasting only a minute or two, and the direction depended on the pattern: intermittent bursts raised excitability in a way that resembles long-term potentiation, the strengthening of connections that underlies learning, while continuous bursts lowered it, resembling long-term depression. That motor-cortex physiology is well established and directly measured. Reading it across to how repeated prefrontal sessions lift mood is a reasonable inference rather than a direct measurement, and the size of any person's response varies.

The Forms And Their Evidence

Standard rTMS For Depression

The oldest and best-evidenced use is repetitive TMS (rTMS) over the left prefrontal cortex for major depression, cleared by the FDA in 2008 for depression that has not responded to medication. In the NIMH-sponsored OPT-TMS trial, 190 adults received daily left prefrontal rTMS or a sham procedure as their only antidepressant, and remission was about 14% with active treatment against 5% with sham over three weeks. Pooling the field tells the fuller story: a meta-analysis of 29 randomized, sham-controlled trials in 1,371 people found response in 29.3% and remission in 18.6% with high-frequency rTMS, versus 10.4% and 5% with sham, with about one extra person responding for every six treated.

Two facts sit together in those numbers. The benefit over sham is real and consistent, and most people do not reach remission, so it is a meaningful option rather than a cure. The sham response, around one in ten, is substantial, which means part of what any individual feels reflects expectation and the attention of daily visits.

Theta-Burst And Accelerated Protocols

The practical problem with standard rTMS is time: a session runs close to forty minutes, which limits how many people a clinic can treat. The THREE-D trial tested whether the three-minute theta-burst version could stand in. In 414 adults with treatment-resistant depression, intermittent theta-burst stimulation matched standard 10 Hz rTMS, with response of 49% against 47% and remission of 32% against 27%, and similar side effects. That result is why theta-burst is now widely used.

A separate line of work compresses the whole course: Stanford Neuromodulation Therapy gives ten short sessions a day for five days, guided by each person's brain scan. In its double-blind trial of 29 people, 79% of the active group reached remission at some point in the following month against 13% with sham. That remission rate is striking and the trial was small and single-site, so it sits at an earlier stage of evidence than the larger depression trials and awaits confirmation.

Deep TMS For OCD

A deeper-reaching coil, worn like a helmet, targets circuits set further in than the standard figure-eight coil can reach, and this "deep TMS" was FDA-cleared for obsessive-compulsive disorder in 2018. In a multicenter, double-blind trial of 99 adults, deep TMS over the medial prefrontal and anterior cingulate cortex, delivered after a brief symptom-provocation, produced a response in 38.1% against 11.1% with sham, and the gain held a month later. A response here means at least a 30% drop in symptoms, a real improvement rather than remission, so most people still had substantial OCD after treatment.

Deep TMS As An Aid To Quitting Smoking

In 2020 deep TMS became the first brain-stimulation treatment FDA-cleared to help adults stop smoking. In a pivotal trial of 262 chronic smokers, deep TMS to the prefrontal and insular cortices, given after a craving cue, produced a four-week continuous quit rate of 19.4% measured through week 18 against 8.7% with sham. As with the other uses, the benefit over sham is clear and most people still smoked, so it is an aid alongside the work of quitting rather than a switch that turns the habit off.

The Research & Studies

Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.

How it works

Theta-burst TMS shifted human cortex excitability for up to an hour, up or down by patternStrong · mixed

In plain terms

Brief patterned magnetic pulses can nudge the brain's activity up or down, and the change outlasts the pulses, which is how repeated sessions are thought to shift the mood-regulating cortex over a course of treatment.

In detail

Huang and colleagues adapted the theta-burst protocol used to induce synaptic long-term potentiation and depression in brain slices into a TMS protocol over the human motor cortex. Bursts of three pulses at 50 Hz repeated at 5 Hz produced lasting, reversible changes in corticospinal excitability measured by motor evoked potentials: the intermittent pattern potentiated responses and the continuous pattern depressed them, for up to an hour. This established that patterned TMS engages plasticity-like mechanisms, and it is the physiological basis for the theta-burst protocols now used in depression.

The study · 1

Huang et al., Theta burst stimulation of the human motor cortex · Neuron 2005;45(2):201-6

Mood & stress

Across 29 trials, high-frequency rTMS responded in 29% versus 10% on sham, remission 19% versus 5%Strong

In plain terms

Pooling the trials, roughly three in ten people respond and about one in five get fully better with TMS, several times the sham rate, so around one extra person responds for every six treated.

In detail

Berlim and colleagues pooled 29 randomized, double-blind, sham-controlled trials of high-frequency rTMS for major depression. High-frequency rTMS was significantly superior to sham on both response (29.3% vs 10.4%) and remission (18.6% vs 5.0%), with pooled odds ratios of 3.3 and numbers needed to treat of 6 and 8. The effect held whether rTMS was used as monotherapy or as augmentation and in unipolar and mixed samples. Drop-out rates were low and similar between arms, indicating good tolerability.

The study · 1

Berlim et al., Response, remission and drop-out rates following high-frequency rTMS for major depression, systematic review and meta-analysis · Psychol Med 2014;44(2):225-39

A 3-minute theta-burst session matched standard 37-minute rTMS, 49% versus 47% responseStrong

In plain terms

A three-minute theta-burst session worked as well as the old thirty-seven-minute treatment, which lets a clinic treat far more people in a day.

In detail

The THREE-D trial (Blumberger et al.) was a large randomized non-inferiority study in treatment-resistant depression comparing iTBS with conventional 10 Hz left prefrontal rTMS, with a non-inferiority margin of 2.25 points on the 17-item Hamilton Rating Scale for Depression. Response (49% vs 47%) and remission (32% vs 27%) were comparable, and side effects, drop-out and tolerability were similar. Because iTBS delivers an equivalent result in a fraction of the time, it is the change that made high-throughput TMS clinics practical.

The study · 1

Blumberger et al., Effectiveness of theta burst versus high-frequency rTMS in patients with depression (THREE-D), a randomised non-inferiority trial · Lancet 2018;391(10131):1683-92

Drug-free rTMS remitted depression in 14% versus 5% on sham, about four times the oddsModerate

In plain terms

In a rigorous drug-free trial, about one in seven people with hard-to-treat depression got fully better with real TMS, against about one in twenty with a fake coil.

In detail

The Optimization of TMS (OPT-TMS) study was a multisite, double-blind, sham-controlled randomized trial funded by the US National Institute of Mental Health, testing daily left dorsolateral prefrontal rTMS as monotherapy in medication-resistant unipolar major depression. In the fixed three-week phase, remission on the primary outcome was reached by about 14% on active versus 5% on sham, with an odds ratio near 4.2. Because it used no concurrent antidepressant and a credible sham, it is one of the stronger single trials of rTMS efficacy, though the short course limits the remission numbers.

The study · 1

George et al., Daily left prefrontal rTMS for acute treatment of medication-resistant depression, a sham-controlled randomized trial (OPT-TMS) · Arch Gen Psychiatry 2010;67(5):507-16

Two-thirds of acute responders were still well at 12 months, under 30% relapsedModerate

In plain terms

Of the people who got better from a course of TMS, most were still well a year later, though some needed a repeat course or maintenance sessions to stay there.

In detail

Dunner and colleagues followed 257 patients with pharmacoresistant major depression who had benefited from acute rTMS, over a naturalistic 12-month period. About two-thirds of acute responders maintained response, relapse was under 30%, and roughly a third received reintroduction of rTMS during the year. Patients also received treatment as usual, so this describes durability in real-world care rather than the durability of a single course in isolation.

The study · 1

Dunner et al., A multisite naturalistic observational study of TMS for pharmacoresistant major depression, durability of benefit over a 1-year follow-up · J Clin Psychiatry 2014;75(12):1394-401

An intensive 5-day theta-burst protocol remitted 79% versus 13% on sham in a small trialEmerging

In plain terms

A compressed five-day version, ten short sessions a day, put most of a small group into remission, far more than the fake treatment and much faster than the usual six weeks.

In detail

Cole and colleagues tested SNT (previously SAINT), an accelerated intermittent theta-burst protocol delivering 10 sessions daily for 5 consecutive days, targeted using each participant's functional MRI connectivity. In this double-blind sham-controlled trial of 29 people with treatment-resistant depression, remission at some point in the 4-week follow-up was 79% with active and 13% with sham. The effect size is far larger than standard protocols, but the sample was small and single-site with brief follow-up, placing it at an emerging stage that needs larger, longer confirmation.

The study · 1

Cole et al., Stanford Neuromodulation Therapy (SNT), a double-blind randomized controlled trial · Am J Psychiatry 2022;179(2):132-41

Anxiety And Stress

Deep TMS responded in 38% versus 11% on sham for OCD at six weeksModerate

In plain terms

For obsessive-compulsive disorder, about two in five people improved with deep TMS against about one in nine with a fake coil, and the improvement lasted at least a month after treatment.

In detail

Carmi and colleagues ran the pivotal prospective multicenter randomized double-blind sham-controlled trial of deep TMS for OCD using the H7 coil to reach the medial prefrontal and anterior cingulate cortex, with high-frequency stimulation delivered after individualized symptom provocation, five days a week for six weeks. Response (a 30% or greater reduction in Y-BOCS) was 38.1% for active and 11.1% for sham, sustained at the one-month follow-up. This trial supported the 2018 FDA clearance of deep TMS for OCD.

The study · 1

Carmi et al., Efficacy and safety of deep TMS for OCD, a prospective multicenter randomized double-blind placebo-controlled trial · Am J Psychiatry 2019;176(11):931-8

Addiction

Deep TMS raised the 4-week continuous quit rate to 19% versus 9% on shamModerate

In plain terms

As an aid to quitting smoking, about one in five people stayed off cigarettes for a month with real TMS, against roughly one in eleven with a fake coil.

In detail

Zangen and colleagues reported the pivotal multicenter double-blind randomized controlled trial of repetitive (deep) TMS for smoking cessation in 262 chronic smokers who had failed prior quit attempts. Bilateral stimulation of the lateral prefrontal and insular cortices was delivered after a cue-induced craving procedure, daily for three weeks then weekly for three weeks. The four-week continuous quit rate through week 18, the primary endpoint, was 19.4% for active versus 8.7% for sham. This was the first large multicenter RCT of brain stimulation in addiction and supported the 2020 FDA clearance.

The study · 1

Zangen et al., Repetitive TMS for smoking cessation, a pivotal multicenter double-blind randomized controlled trial · World Psychiatry 2021;20(3):397-404

Go Deeper

• Depression: what actually helps: the full range of options for depression and where a clinic treatment like TMS sits among the things with a longer track record.
• Ketamine and esketamine: the other fast-acting, clinic-administered option for treatment-resistant depression, and how its rapid effect and durability limit compare.
• Vagus nerve stimulation: a different neurostimulation family, from an implanted device to an ear clip, with its own evidence and cautions.
• Quitting smoking: the wider set of tools for stopping, where deep TMS is one recently cleared aid.

The Chinese Medicine View

Chinese medicine has no account of a magnetic field or a cortex, because it does not describe the body through the brain and nerves at all. What it does describe, in detail, is the territory a treatment for low mood would touch, and the overlap reads best as one language laid over the same person rather than a proof of either account. The Heart is said to house the Shen, the mind and spirit, and clear thought, steady feeling and restful sleep are read as signs of a settled Shen. Persistent low mood is more often traced to the Liver: the Liver is meant to keep Qi moving smoothly through the body, and when that movement stalls, a pattern called Liver Qi stagnation, the classical picture includes a low, stuck, irritable heaviness. Long-standing cases are read as stagnation turning to heat, or as the Heart and Spleen weakening so that the Shen is no longer nourished.

Read through that lens, a treatment for depression would be understood as moving what is stuck and settling and nourishing the Shen, and the tradition would ask first about the person's constitution and pattern rather than reaching for one intervention for everyone. That is an interpretation, offered as a way of seeing, and its limit is plain: the classical texts describe none of the machinery TMS acts on and did not anticipate a device that induces a current in the cortex. The two accounts were built independently, and neither certifies the other. Where the classical preventive tradition of Yang Sheng, nourishing life, would put its weight is on the daily ground of sleep, movement, food and calm, and it would read a potent clinic treatment as something for a serious, established case rather than a first move.

Cautions For This Practice

Extra restraint

Everything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.

Seizures were rare, about 0.3 per 10,000 sessions across 587,000 sessions

Taylor and colleagues surveyed members of the Clinical TMS Society about seizures in their practices, capturing 586,656 sessions across 25,526 patients from all manufacturers, with 18 seizures reported, giving an overall rate of 0.31 per 10,000 sessions and 0.71 per 1,000 patients. Rates were higher for H-coil (deep) than figure-8 devices. The estimate is consistent with theta-burst safety data showing per-session seizure risk under about 0.02 to 0.03 percent, and it frames the seizure risk as low but not zero.Taylor et al., Seizure risk with repetitive TMS, survey results from over a half-million treatment sessions

Metal and electronic implants in or near the head

The strong magnetic field is the reason for the main hard limit. Ferromagnetic or electronic hardware in the head or close to the coil, such as aneurysm clips, cochlear implants, deep-brain or vagus-nerve stimulators, metal fragments in the eye or skull, or stents and coils near the treatment area, can heat, move or malfunction in the field, so TMS is generally not done in that setting. Dental fillings and braces are usually fine. This is a screening question the clinic asks before treatment, and it is the single most common reason someone cannot have TMS.

Seizure risk, rare but real

The one serious risk is triggering a seizure. It is rare: a survey covering 586,656 sessions recorded about 0.3 seizures per 10,000 sessions, and it was higher with the deeper-reaching H-coils than with the standard figure-eight coil. The risk rises with a personal history of seizures or epilepsy, with medications and stimulants that lower the seizure threshold, and with sleep deprivation or heavy alcohol use, all of which the clinic screens for. A seizure during TMS is brief and self-limiting, and the setting is prepared for it.

Common, mild effects during and after a session

Most side effects are minor and settle over the first week or two of treatment. Scalp discomfort or pain at the coil site during the pulses is the most common, along with headache afterward, and some people notice twitching of the face or jaw while the train runs. These tend to ease as the scalp gets used to it and the strength can be adjusted. The loud clicking is why earplugs are worn, since the sound can affect hearing over a long course.

Bipolar disorder, pregnancy, and severe depression

In someone with bipolar disorder, stimulation aimed at lifting mood can occasionally tip toward a manic or agitated state, so it is used with a mood-stabilizing plan and specialist oversight. Data in pregnancy are limited; TMS avoids the systemic drug exposure of medication, which is part of why it is considered, but it is a decision to make with a clinician. For severe depression, especially with any thoughts of self-harm, TMS is one part of care under a clinician and not a reason to delay urgent help; if low mood is severe or you are having thoughts of harming yourself, reach a clinician or a crisis line now.

TMS is a real, regulated clinic treatment with consistent trial evidence for treatment-resistant depression and clearances for OCD and smoking cessation. The stance here is to inform: read the benefit at its true strength, hold the durability limit and the substantial sham response in view, take the metal-implant and seizure cautions seriously, and work with a qualified clinic for anything touching your own care.

Common Questions

Does TMS actually work for depression?

For depression that has not responded to medication, yes, at a real but moderate size. Pooling 29 sham-controlled trials, about three in ten people respond and roughly one in five reach remission with high-frequency TMS, against about one in ten and one in twenty with a sham coil, so around one extra person responds for every six treated. The benefit over the sham is consistent across trials. It also means most people do not reach remission, which is why TMS is described as a meaningful option rather than a cure, and why newer accelerated protocols are being tested to push the numbers higher.

What is a TMS session like, and is it the same as shock therapy?

It is not the same. A TMS session is done sitting awake in a chair with no anesthesia: a coil rests against the scalp and delivers pulses that feel like a firm tapping, with a loud click, over about twenty to forty minutes, or about three minutes for the theta-burst version, and the person can drive home afterward. Electroconvulsive therapy is a different, stronger treatment that passes a current across the whole brain under general anesthesia to trigger a brief seizure on purpose. TMS does not aim to cause a seizure and needs no sedation.

Is TMS safe, and can it cause a seizure?

For most people it is well tolerated, and the common effects are mild: scalp discomfort during the pulses and a headache afterward, usually easing over the first couple of weeks.

The one serious risk is a seizure, which is rare, on the order of 0.3 per every 10,000 sessions in a large survey, and higher with the deeper-reaching coils.

Risk rises with a history of seizures, with medications that lower the seizure threshold, and with sleep loss or heavy drinking, all of which the clinic screens for before treatment.

Who should not have TMS, and does the benefit last?

The main reason someone cannot have TMS is ferromagnetic or electronic hardware in or near the head, such as aneurysm clips, cochlear implants or a neurostimulator, because of the magnetic field; dental fillings and braces are usually fine. Bipolar disorder, pregnancy and a history of seizures call for specialist judgment rather than a flat no. As for lasting: when a course works, most people who responded are still well a year later in follow-up studies, and fewer than three in ten relapse, though some need a repeat course or maintenance sessions to hold the gain.